These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9606228)

  • 1. Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors.
    Piedra PA; Poveda GA; Ramsey B; McCoy K; Hiatt PW
    Pediatrics; 1998 Jun; 101(6):1013-9. PubMed ID: 9606228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.
    Harvey BG; Hackett NR; El-Sawy T; Rosengart TK; Hirschowitz EA; Lieberman MD; Lesser ML; Crystal RG
    J Virol; 1999 Aug; 73(8):6729-42. PubMed ID: 10400771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus infection in cystic fibrosis patients: implications for the use of adenoviral vectors for gene transfer.
    Rosenecker J; Harms KH; Bertele RM; Pohl-Koppe A; v Mutius E; Adam D; Nicolai T
    Infection; 1996; 24(1):5-8. PubMed ID: 8852455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infection rate with adenivirus 1 to 39 in infants and adults].
    Fatz W; Wigand R
    Immun Infekt; 1985 May; 13(3):108-12. PubMed ID: 2408993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1a sequences relevant to the use of E1a- adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis.
    Eissa NT; Chu CS; Danel C; Crystal RG
    Hum Gene Ther; 1994 Sep; 5(9):1105-14. PubMed ID: 7833370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines.
    Appaiahgari MB; Pandey RM; Vrati S
    Clin Vaccine Immunol; 2007 Aug; 14(8):1053-5. PubMed ID: 17596429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.
    Halbert CL; Miller AD; McNamara S; Emerson J; Gibson RL; Ramsey B; Aitken ML
    Hum Gene Ther; 2006 Apr; 17(4):440-7. PubMed ID: 16610931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa.
    Thorner AR; Vogels R; Kaspers J; Weverling GJ; Holterman L; Lemckert AA; Dilraj A; McNally LM; Jeena PM; Jepsen S; Abbink P; Nanda A; Swanson PE; Bates AT; O'Brien KL; Havenga MJ; Goudsmit J; Barouch DH
    J Clin Microbiol; 2006 Oct; 44(10):3781-3. PubMed ID: 17021110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serological survey of human adenovirus serotype 2 and 5 circulating pediatric populations in Changchun, China, 2011.
    Yu B; Wang Z; Dong J; Wang C; Gu L; Sun C; Kong W; Yu X
    Virol J; 2012 Nov; 9():287. PubMed ID: 23176136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimeric knob protein specifically distinguishes neutralizing antibodies to different human adenovirus species: potential application for adenovirus seroepidemiology.
    Yu B; Dong J; Wang C; Wang Z; Gao L; Zhang H; Wu J; Kong W; Yu X
    J Gen Virol; 2014 Jul; 95(Pt 7):1564-1573. PubMed ID: 24764358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.
    Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B
    J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired humoral responses to subgenus D adenovirusenovirus infections in HIV-positive patients.
    Lord A; Bailey AS; Klapper PE; Snowden N; Khoo SH
    J Med Virol; 2000 Dec; 62(4):405-9. PubMed ID: 11074466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.
    Mastrangeli A; Harvey BG; Yao J; Wolff G; Kovesdi I; Crystal RG; Falck-Pedersen E
    Hum Gene Ther; 1996 Jan; 7(1):79-87. PubMed ID: 8825871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of adenovirus 36 as a risk factor in obesity: the first clinical study made in the fatty tissues of adults in Turkey.
    Ergin S; Altan E; Pilanci O; Sirekbasan S; Cortuk O; Cizmecigil U; Ersin I; Elbey H; Dinc HO; Habip Z; Turan N; Arinci A; Richt JA; Goossens VJ; Karakullukcu A; Kocak BT; Saribas S; Koksal S; Yilmaz H; Kocazeybek B
    Microb Pathog; 2015 Mar; 80():57-62. PubMed ID: 25720551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to enteric adenoviruses (Ad40 and Ad41) in sera from Iranian children.
    Saderi H; Roustai MH; Sabahi F
    J Clin Virol; 2000 Apr; 16(2):145-7. PubMed ID: 10720819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human adenovirus-36 antibody status is associated with obesity in children.
    Atkinson RL; Lee I; Shin HJ; He J
    Int J Pediatr Obes; 2010 Apr; 5(2):157-60. PubMed ID: 19593728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines.
    Pilankatta R; Chawla T; Khanna N; Swaminathan S
    J Med Virol; 2010 Mar; 82(3):407-14. PubMed ID: 20087930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to enteric adenovirus types 40 and 41 in sera from people in various age groups.
    Shinozaki T; Araki K; Ushijima H; Fujii R
    J Clin Microbiol; 1987 Sep; 25(9):1679-82. PubMed ID: 3654940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China.
    Zheng X; Rong X; Feng Y; Sun X; Li L; Wang Q; Wang M; Liu W; Li C; Yang Y; Zhou R; Lu J; Feng L; Chen L
    Emerg Microbes Infect; 2017 Jun; 6(6):e43. PubMed ID: 28588291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus infection and specific secretory IgA responses in the intestine of infants.
    Nishio O; Sakae K; Ishihara Y; Isomura S; Inouye S
    Microbiol Immunol; 1992; 36(6):623-31. PubMed ID: 1522811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.